ASNS Arsanis Inc.

3.74
-0.19  -5%
Previous Close 3.93
Open 3.8
Price To Book 1.92
Market Cap 53539633
Shares 14,315,410
Volume 683,564
Short Ratio
Av. Daily Volume 2,296,652

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 2 trial to be discontinued due to futility - June 28, 2018.
ASN100
Staphylococcus aureus